Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy

Código QR

Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy

Yasser Bayoumi,1 Ayman AbdelSamie,2 Ahmed Abdelsaid,3 Aida Radwan4 1Radiation Oncology, 2Medical Oncology, 3Surgical Oncology, 4Medical Physics, National Cancer Institute, Cairo University, Cairo, Egypt Background/purpose: The aim was to evaluate the prognostic significance of postoperative radiot...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bayoumi Y, AbdelSamie A, Abdelsaid A, Radwan A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/63d5d7c5d9ef48b0b60c86f218925a6e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
por: Sung Uk Lee MD, et al.
Publicado: (2021)

Epigenomic alterations in breast carcinoma from primary tumor to locoregional recurrences.
por: Matahi Moarii, et al.
Publicado: (2014)

Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer
por: Priyanka Narayan, et al.
Publicado: (2021)

Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study
por: Dengpan Song, et al.
Publicado: (2021)

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer
por: Megumi Kai, et al.
Publicado: (2021)

FREQUENCY OF PATHOLOGICAL COMPLETE RESPONSE (PCR) IN PATIENTS OF TRIPLE NEGATIVE BREAST CANCER AFTER NEO-ADJUVANT CHEMOTHERAPY
por: Zeeshan Ahmed Khan Niazi, et al.
Publicado: (2021)

Non-coplanar volumetric modulated arc therapy for locoregional radiotherapy of left-sided breast cancer including internal mammary nodes
por: Xu Yuan, et al.
Publicado: (2021)

Changes in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study
por: AlSaeed EF, et al.
Publicado: (2017)

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
por: Nina Radosevic-Robin, et al.
Publicado: (2021)

Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan.
por: Lee H Chen, et al.
Publicado: (2011)

Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
por: Moonkyoo Kong, et al.
Publicado: (2021)

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
por: Maria Vittoria Dieci, et al.
Publicado: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)

Factors associated with locoregional recurrence in penile cancer: a case-control study
por: Aldo Zárate-González, et al.
Publicado: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
por: Inna P. Ganshina, et al.
Publicado: (2021)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
por: Wen-Hung Kuo, et al.
Publicado: (2012)

Radiotherapy in the Adjuvant and Advanced Setting of CSCC
por: Paolo Muto, et al.
Publicado: (2021)

Dermatofibrosarcoma Protuberans and Adjuvant Radiotherapy: A Case Report with Uncertain Surgical Margins in The Breast
por: Alaettin Arslan, et al.
Publicado: (2021)

Single nucleotide polymorphisms and unacceptable late toxicity in breast cancer adjuvant radiotherapy: a case report
por: Lazzari G, et al.
Publicado: (2017)

BRCA2 mutations and triple-negative breast cancer.
por: Peter Meyer, et al.
Publicado: (2012)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon J, et al.
Publicado: (2016)

Opportunities for metastatic triple negative breast cancer therapy
por: Inna P. Ganshina, et al.
Publicado: (2021)

Effect of Prophylactic Central Lymph Node Dissection on Locoregional Recurrence in Patients with Papillary Thyroid Microcarcinoma
por: Peipei Yang, et al.
Publicado: (2021)

Impact of CBCT frequency on target coverage and dose to the organs at risk in adjuvant breast cancer radiotherapy
por: Kai J. Borm, et al.
Publicado: (2021)

Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial
por: Si‐Yuan Zhu, et al.
Publicado: (2021)

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
por: Yu-Hsiang Chen, et al.
Publicado: (2017)

A new immunochemical strategy for triple-negative breast cancer therapy
por: Chih-Wei Lin, et al.
Publicado: (2021)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Marina K. Ibragimova, et al.
Publicado: (2021)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman ML, et al.
Publicado: (2015)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Paolo Peterlongo, et al.
Publicado: (2021)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Anna E. M. Bastiaansen, et al.
Publicado: (2020)

Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients
por: Yujiao Deng, et al.
Publicado: (2021)

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study
por: Anna-Karin Wennstig, et al.
Publicado: (2021)

Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?
por: Lazzari G, et al.
Publicado: (2021)

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
por: L. E. Anselmino, et al.
Publicado: (2021)

Peptide density targets and impedes triple negative breast cancer metastasis
por: Daxing Liu, et al.
Publicado: (2018)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Gábor Cserni, et al.
Publicado: (2021)